Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. scores highest on Earnings (42) and lowest on Price (0). Its PosiPenta is 18.60 out of 100, clearly weaker than most similar companies.
On the Penta Grid this week, Tempest Therapeutics, Inc. is Grid #833 of 837 in the Healthcare sector in United States, and Grid #3,963 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Tempest Therapeutics, Inc. | 18.60 | 0 | 42 | 5 | 9 | 37 |
| Alaunos Therapeutics, Inc. | 40.95 | 6 | 50 | 65 | 52 | 32 |
| NeuroOne Medical Technologies Corporation | 37.95 | 26 | 58 | 11 | 41 | 53 |
| Theriva Biologics, Inc. | 45.24 | 89 | 43 | 28 | 33 | 32 |
| Bullfrog AI Holdings, Inc. | 40.93 | 35 | 63 | 28 | 48 | 32 |
| MetaVia Inc. | 33.07 | 37 | 19 | 16 | 42 | 51 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.16 |
| P/B ratio | -9.67 |
EEarnings
| Trailing EPS | ₹-372.23 |
| Forward EPS | ₹-114.61 |
NNitro
| Price | 59.12 |
| 52-week high | 1055.98 |
| 52-week low | 58.72 |
| Fall from 52-week high | 94.4% |
TTorque
| Return on equity (ROE) | -931.14% |
| Debt-to-equity | 1.22 |
AAnchor
| Beta (price swings) | -1.71 |
| Market cap | ₹99 Cr |
| Insider holding | 30.07% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Tempest Therapeutics, Inc.'s PosiPenta score?
Tempest Therapeutics, Inc.'s PosiPenta is 18.60 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Tempest Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Tempest Therapeutics, Inc. is Grid #833 of 837 in the Healthcare sector in United States, and Grid #3,963 of 4,000 in United States.
Which PosiPenta pillar is strongest for Tempest Therapeutics, Inc.?
Earnings (growth), with a score of 42 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Tempest Therapeutics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.